🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12006+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12006 recruiting trials

Phase 1RecruitingNCT06414902

18F-AraG PET/CT as a Non-Invasive Imaging Biomarker for Chemoradiation Treatment Response in Esophageal Cancer

👨‍⚕️ Steven Lin, MD, M.D. Anderson Cancer Center📍 1 site📅 Started Sep 2024View details ↗
Phase 2RecruitingNCT06581198

A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)

👨‍⚕️ Novartis Pharmaceuticals, Novartis Pharmaceuticals📍 93 sites📅 Started Sep 2024View details ↗
Phase 2, PHASE3RecruitingNCT06011889

Study of the Efficacy and Safety of Etanercept Treatment in Patients With SAPHO Syndrome

👨‍⚕️ Jakub Wroński, PhD, MD, National Institute of Geriatrics, Rheumatology and Rehabilitation📍 1 site📅 Started Sep 2024View details ↗
NARecruitingNCT06803082

The Impact of Systemic Light Chain Amyloidosis on Eyes

👨‍⚕️ chang he, Zhongshan Ophthalmic Center, Sun Yat-sen University📍 1 site📅 Started Sep 2024View details ↗
Phase 1RecruitingNCT06484985

Study of AXT-1003 in Subjects With Advanced Malignant Tumors.

👨‍⚕️ Qian Gao, Axter Therapeutics (Beijing) Co., Ltd📍 5 sites📅 Started Sep 2024View details ↗
NARecruitingNCT06584123

Molecular Pituitary Imaging Using 18F-FET PET

👨‍⚕️ Mark Gurnell, MD, PhD, Cambridge University Hospitals NHS Foundation Trust📍 1 site📅 Started Sep 2024View details ↗
Phase 2RecruitingNCT07437898

Neoadjuvant Adebrelimab Plus Chemotherapy for Esophageal Cancer: A Clinical Study

🏥 The Affiliated Hospital of Putian University📍 1 site📅 Started Sep 2024View details ↗
Phase 3RecruitingNCT06512584

Efficacy and Safety of PJ009 in Patients With Short Bowel Syndrome Requiring Parenteral Nutrition

👨‍⚕️ Huanlong Qin, Shanghai 10th People's Hospital📍 8 sites📅 Started Sep 2024View details ↗
Phase 1, PHASE2RecruitingNCT06364423

Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias

👨‍⚕️ James N Kochenderfer, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Sep 2024View details ↗
RecruitingNCT07463937

A RWS of SC MTX in Chinese RA Patients

🏥 Peking University People's Hospital📍 1 site📅 Started Sep 2024View details ↗
Phase 2RecruitingNCT06592599

Gemcitabine + Docetaxel + Toripalimab Induction in Epstein-Barr Virus (EBV) Associated Nasopharyngeal Carcinoma(NPC)

👨‍⚕️ A. Dimitrios Colevas, MD, Stanford University📍 1 site📅 Started Sep 2024View details ↗
Phase 3RecruitingNCT06635798

A Phase III Clinical Trail to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity Characteristics of GR2001 Injection

👨‍⚕️ Chuanlin Wang, MD, Peking University People's Hospital📍 20 sites📅 Started Sep 2024View details ↗
Phase 1RecruitingNCT06576271

A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants

👨‍⚕️ GSK Clinical Trials, GlaxoSmithKline📍 26 sites📅 Started Sep 2024View details ↗
Phase 2RecruitingNCT06544785

Zanubrutinib With Obinutuzumab in Untreated Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

👨‍⚕️ Pau Abrisqueta, Hospital Universitari Vall d'Hebrón📍 1 site📅 Started Sep 2024View details ↗
Phase 1, PHASE2RecruitingNCT06283719

Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Advanced Small Cell Lung Cancer

👨‍⚕️ Jason Wu, Suzhou Zelgen Biopharmaceuticals Co.,Ltd📍 1 site📅 Started Sep 2024View details ↗
Phase 2, PHASE3RecruitingNCT06477536

Long-Term Safety and Efficacy of HB0034 in Subjects With Generalized Pustular Psoriasis

👨‍⚕️ Jianzhong Zhang, PhD, Peking University People's Hospital (PKUPH)📍 3 sites📅 Started Sep 2024View details ↗
Phase 2RecruitingNCT06812858

PD-1 Inhibitors Maintenance for cHL Post-autoHCT

👨‍⚕️ Natalia Mikhailova, MD, St. Petersburg State Pavlov Medical University📍 3 sites📅 Started Sep 2024View details ↗
NAEnrolling by InvitationNCT06822621

Functional Cereal Products and Contribution to the Regulation of Metabolism and Obesity-induced Chronic Low-grade Inflammation.

👨‍⚕️ Amalia E Yanni, Senior Researcher, Harokopio University📍 1 site📅 Started Sep 2024View details ↗
RecruitingNCT06667414

Frequency of Selected Single Nucleotide Polymorphisms in Huntington Disease Gene Expansion Carriers

👨‍⚕️ Clinical Trials, Hoffmann-La Roche📍 45 sites📅 Started Sep 2024View details ↗
NARecruitingNCT03849534

Treatment of Temporomandibular Disorders in Children and Adolsecents

👨‍⚕️ Nikolaos Christidis, PhD, Karolinska Institutet, Department of Dental Medicine📍 1 site📅 Started Sep 2024View details ↗
← PreviousPage 244 of 601Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →